Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07578376 · ClinicalTrials.gov registry record · NA
Empowered Relief® for Cancer Survivors With Chronic Pain
A NA study, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- NA
- Development phase
- 215
- Enrollment target
NCT07578376: Recruiting NA study, sponsored by University of Oklahoma.
NCT07578376 is a NA study that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 215 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07578376, a NA study, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- NA
- Development phase
- 215 participants
- Enrollment target
Study Summary
This randomized controlled study to examine the efficacy of ER class in cancer survivors with chronic pain. Eligible participants will be randomly assigned to a ER class or a waitlist control condition. We will recruit 250 participants with a goal of having 200 completers (20% attrition). Participants in the control condition will be invited to attend ER class after the 3-month observation period.
Primary Outcome
0-10 scale, higher scores indicate greater satisfaction, mean should be 8 or higher
Interventions
- BEHAVIORAL Empowered Relief Course (Zoom)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 215 participants |
| Start Date | 2026-06 |
| Est. Completion | 2030-04-30 |
| Phase | NA |
What NCT07578376 shows while recruiting
NCT07578376 is an interventional study that assigns participants to a tested intervention. The registered 215 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which Empowered Relief Course (Zoom) is the first listed.
NCT07578376 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07578376 about?
NCT07578376 is a clinical study titled "Empowered Relief® for Cancer Survivors With Chronic Pain". This randomized controlled study to examine the efficacy of ER class in cancer survivors with chronic pain. Eligible participants will be randomly assigned to a ER class or a waitlist control condition. We will recruit 250 participants with a goal of having 200 completers (20% attrition). Participan...
What is the current status of trial NCT07578376?
This trial is currently recruiting. It is a NA study. The enrollment target is 215 participants. The study started on 2026-06. Estimated completion is 2030-04-30.
What interventions are being tested in trial NCT07578376?
The interventions under investigation include: Empowered Relief Course (Zoom) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07578376?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07578376's enrollment target sits among peer trials
215 487th of 2000 higher than 1,514 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05134012 · 215 participants · Phase 3
RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)
- NCT05169970 · 215 participants · Phase 2
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer
- NCT05197270 · 215 participants · Phase 1
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- NCT05230199 · 215 participants · NA
Sensory Optimization of the Hospital Environment
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia